Clinical trial
Surgery Plus Medroxyprogesterone in Preventing Endometrial Cancer
NCT00003179 · Gynecologic Oncology Group, Other · Terminated
Key facts
| NCT number | NCT00003179 |
|---|---|
| Title | Surgery Plus Medroxyprogesterone in Preventing Endometrial Cancer |
| Official title | A Two-Part Study of the Treatment of Atypical Endometrial Hyperplasia: Part A: A Prospective Study of Immediate Hysterectomy; Part B: A Randomized Phase II Study of Medroxyprogesterone Acetate Versus Depoprovera |
| Lead sponsor | Gynecologic Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Endometrial Cancer |
| Intervention type | Drug |
| Interventions | medroxyprogesterone |
| Enrollment | 360 |
| Start date | Nov 1, 1998 |
| Primary completion | Feb 1, 2006 |
| First posted | Jan 27, 2003 |
| Last update posted | Jun 10, 2013 |
| Countries | Norway, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: